Pharma News

Pfizer
Pfizer Inc. (NYSE:PFE) today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults. RSV affects 33 million [...]
Tue, May 22, 2018
Source Pharmanews
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat severe asthma. In a study of over 200 participants with severe asthma, the new treatment was shown to have improved [...]
Tue, May 22, 2018
Source Pharmanews
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable anti-inflammatory drug, was approved in 2017 by the Food and Drug Administration as a treatment for eczema, a chronic skin [...]
Mon, May 21, 2018
Source Pharmanews
Novartis
Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held June 1-5 in Chicago; and the 23rd Annual Congress of the European Hematology Association (EHA), scheduled for June 14-17 in Stockholm. [...]
Mon, May 21, 2018
Source Pharmanews

связаться с нами
Medial D&P Ltd.
Gewerbestrasse 18
4123 Allschwil
Швейцария
звоните: +41 61 487 96 22
факс. +41 61 487 96 20
medial@medialpharma.com